Akebia Therapeutics, Inc. (AKBA) Profit Margins
Over the twelve months to 2026-06-30, Akebia Therapeutics, Inc. (AKBA) had gross margin 79.6%, operating margin -6.9%, net margin -13.5%, free cash flow margin 18.4%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AKBAAkebia Therapeutics, Inc.Follow AKBA — free
—
Price chart with a free account
- Market cap
- 157.1M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 29 Oct, in 5 days
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 96.3% | 56.6% | -0.6% | 28.8% | 70.7% | 61.9% | 60.6% | 83.3% | 79.6% | |
| Operating margin | -85.8% | -85.5% | -128.2% | -125.0% | -27.6% | -23.8% | -31.5% | 9.9% | -6.9% | |
| Net margin | -69.1% | -83.5% | -130.6% | -133.3% | -32.2% | -26.7% | -43.3% | -2.3% | -13.5% | |
| FCF margin | -47.7% | -78.8% | -37.6% | -119.5% | -25.1% | -12.0% | -25.4% | 28.7% | 18.4% |
USD millions · SEC XBRL
Akebia Therapeutics, Inc. — questions
- What is Akebia Therapeutics, Inc.'s gross margin?
- 79.6% over the twelve months to 2026-06-30.
- What is Akebia Therapeutics, Inc.'s operating margin?
- -6.9% over the twelve months to 2026-06-30.
- What is Akebia Therapeutics, Inc.'s net profit margin?
- -13.5% over the twelve months to 2026-06-30.
Every figure on this page comes from Akebia Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.